GeneDx Holdings Corp. (WGS)
$85.19-2.15%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV45.6%–254.9%
- Market cap
- $2.5B
- Avg volume
- 1.2M
- Beta
- 1.98
- P/E (TTM)
- -23.40
- IV-%ile
- 44
- IV ATM
- 74.7%
- Short % float
- 21.34%
- Days to cover
- 8.6
- SI change
- +0.3%
- 1W
- +10.08%
- 1M
- +44.15%
- 3M
- +80.07%
- YTD
- -35.61%
- vs SPY 1W
- +11.27%
- vs SPY 1M
- +40.82%
- vs SPY 3M
- +77.68%
- vs SPY YTD
- -47.36%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ELABSELLPMGC Holdings Inc.CRISISQ -30$6.52-2.10%
- BYSISELLBeyondSpring Inc.CRISISQ -2$0.71-1.39%
- RLYBBUYRallybio CorporationBULLQ -2$16.80-0.18%
- LABSELLStandard BioTools Inc.CRISISQ -6$0.65-2.99%
- MIRASELLMIRA Pharmaceuticals, Inc.CRISISQ -10$0.79+3.95%
- PLYXSELLPolaryx Therapeutics, Inc. Common StockQ -31$1.87-9.66%
- TELOSELLTelomir Pharmaceuticals, Inc. Common StockRECOVERYQ -12$1.17+3.54%
- SMTIBUYSanara MedTech Inc.BULLQ 7$34.38-0.20%
- UPCSELLUniverse Pharmaceuticals Inc.CRISISQ -21$5.36+1.13%
- KROSBUYKeros Therapeutics, Inc.RECOVERYQ -7$10.78-2.27%
- DHAISELLDIH Holding US, Inc.CRISISQ -21$0.00
- BNGOBUYBionano Genomics, Inc.RECOVERYQ -8$1.22+1.67%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRBUYKymera Therapeutics, Inc.$10.0BBULLQ 27$121.38+1.04%
- IMVTBUYImmunovant, Inc.$9.1BBULLQ 30$44.30-2.37%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.72+0.11%
- OSCRBUYOscar Health, Inc.$8.1BRECOVERYQ 11$31.28-0.72%
- HNGEBUYHinge Health, Inc.$6.8BRECOVERYQ 71$88.24+1.76%
- VKTXSELLViking Therapeutics, Inc.$3.9BRECOVERYQ 23$33.37-1.95%
- OPCHBUYOption Care Health, Inc.$3.5BRECOVERYQ 6$23.41-0.13%
- NAMSSELLNewAmsterdam Pharma Company N.V.$3.2BRECOVERYQ 29$27.25-3.66%
- TMDXBUYTransMedics Group, Inc.$3.1BRECOVERYQ 28$90.69-1.23%
- PRVASELLPrivia Health Group, Inc.$2.7BCRISISQ 13$21.52-0.47%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 9
- VALUE
- 4
- GROWTH
- 28
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-23.2%
REV YoY-
ROE-38.7%
EPS YoY-
ROA-22.1%
GROSS68
OP-13
NET-23
[VALUATION]
P/E TTM-23.40
P/E FWD-
SECTOR PE22.66
INDUSTRY PE31.25
P/B10.36
P/FCF-
EV/EBITDA-34.64
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E68.55
ALTMAN Z-
CURR RATIO3.30
ND/EBITDA-
BETA1.98
